Loading...
Header Logo
Keywords
Last Name
Institution

MARC L. FLEMING

TitleAssistant Professor
InstitutionUniversity of Houston College of Pharmacy
DepartmentPharmaceutical Health Outcomes and Policy
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rickles NM, Fleming ML, Björnsdottir I. Global research initiatives to understand the prescription drug misuse epidemic and ways to monitor and intervene. Res Social Adm Pharm. 2019 Aug; 15(8):907-909. PMID: 31151917.
      View in: PubMed
    2. Upadhyay N, Aparasu R, Rowan PJ, Fleming ML, Balkrishnan R, Chen H. The association between geographic access to providers and the treatment quality of pediatric depression. J Affect Disord. 2019 Jun 15; 253:162-170. PMID: 31035217.
      View in: PubMed
    3. Fleming ML, Bapat SS, Varisco TJ. Using the theory of planned behavior to investigate community pharmacists' beliefs regarding engaging patients about prescription drug misuse. Res Social Adm Pharm. 2019 Aug; 15(8):992-999. PMID: 30442574.
      View in: PubMed
    4. Fernandez J, Thornton JD, Rege S, Lewing B, Bapat S, Xu Q, Fleming ML. Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study. J Opioid Manag. 2018 Sep/Oct; 14(5):317-326. PMID: 30387855.
      View in: PubMed
    5. Sansgiry SS, Bhansali A, Serna O, Kamdar M, Fleming M, Abughosh S, Stanford RH. Effect of coverage gap on healthcare utilization among Medicare beneficiaries with chronic obstructive pulmonary disorder. Curr Med Res Opin. 2019 Feb; 35(2):321-328. PMID: 29962241.
      View in: PubMed
    6. Ferries EA, Gilson AM, Aparasu RR, Chen H, Johnson ML, Fleming ML. Prevalence and Factors Associated with Multiple Provider Episodes in Texas: An Epidemiological Analysis of Prescription Drug Monitoring Program Data. Pain Med. 2017 Oct 01; 18(10):1941-1951. PMID: 27744401.
      View in: PubMed
    7. Ferries EA, Gilson AM, Aparasu RR, Chen H, Johnson ML, Fleming ML. The Prevalence of and Factors Associated With Receiving Concurrent Controlled Substance Prescriptions. Subst Use Misuse. 2017 Oct 15; 52(12):1639-1645. PMID: 28557587.
      View in: PubMed
    8. Abughosh S, Wang X, Serna O, Esse T, Mann A, Masilamani S, Holstad MM, Essien EJ, Fleming M. A Motivational Interviewing Intervention by Pharmacy Students to Improve Medication Adherence. J Manag Care Spec Pharm. 2017 May; 23(5):549-560. PMID: 28448784.
      View in: PubMed
    9. Varisco TJ, Ogunsanya ME, Barner JC, Fleming ML. Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes. J Am Pharm Assoc (2003). 2017 Mar - Apr; 57(2S):S51-S62. PMID: 28292504.
      View in: PubMed
    10. Hickerson SC, Fleming ML, Sawant RV, Ordonez ND, Sansgiry SS. Predicting pharmacy students' intention to apply for a residency: A systematic theory of planned behavior approach. Curr Pharm Teach Learn. 2017 Jan - Feb; 9(1):12-19. PMID: 29180144.
      View in: PubMed
    11. Mhatre SK, Serna O, Sansgiry S, Fleming ML, Essien EJ, Sansgiry SS. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool. J Manag Care Spec Pharm. 2016 Nov; 22(11):1293-1301. PMID: 27783546.
      View in: PubMed
    12. Fleming ML, Driver L, Sansgiry SS, Abughosh SM, Wanat M, Sawant RV, Ferries E, Reeve K, Todd KH. Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach. Res Social Adm Pharm. 2017 May - Jun; 13(3):503-512. PMID: 27567741.
      View in: PubMed
    13. Bhansali AH, Fleming ML, Sherer JT, Sansgiry SS. Improving Information Processing: The Effect of Label Format Among Current and Potential Over-the-Counter Medication Users. Ther Innov Regul Sci. 2016 Sep; 50(5):560-568. PMID: 30231764.
      View in: PubMed
    14. Bali V, Holmes HM, Johnson ML, Chen H, Fleming ML, Aparasu RR. Comparative Effectiveness of Second-Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression. Pharmacotherapy. 2016 Jan; 36(1):38-48. PMID: 26748455.
      View in: PubMed
    15. Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, Chung N, Fleming M. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan. J Manag Care Spec Pharm. 2016 Jan; 22(1):63-73. PMID: 27015053.
      View in: PubMed
    16. Bali V, Johnson ML, Chen H, Fleming ML, Holmes HM, Aparasu RR. Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression. Ann Pharmacother. 2016 Feb; 50(2):96-105. PMID: 26610873.
      View in: PubMed
    17. Fleming ML, Phan Y, Ferries EA, Hatfield MD. Educating Pharmacists on a Prescription Drug Monitoring Program. J Pharm Pract. 2016 Dec; 29(6):543-548. PMID: 25947949.
      View in: PubMed
    18. Fleming ML, Wanat MA. To prescribe codeine or not to prescribe codeine? J Pain Palliat Care Pharmacother. 2014 Sep; 28(3):251-4. PMID: 25102040.
      View in: PubMed
    19. Wanat MA, Fleming ML, Fernandez JM, Garey KW. Education, training, and academic experience of newly hired, first-time pharmacy faculty members. Am J Pharm Educ. 2014 Jun 17; 78(5):92. PMID: 24954932.
      View in: PubMed
    20. Fleming ML, Barner JC, Brown CM, Shepherd MD, Strassels SA, Novak S. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions. J Am Pharm Assoc (2003). 2014 May-Jun; 54(3):241-50. PMID: 24816350.
      View in: PubMed
    21. Fleming ML, Hatfield MD, Wattana MK, Todd KH. Exploratory study of emergency physicians' use of a prescription monitoring program using a framework of technology acceptance. J Pain Palliat Care Pharmacother. 2014 Mar; 28(1):19-27. PMID: 24520884.
      View in: PubMed
    22. Fleming ML, Barner JC, Brown CM, Shepherd MD, Strassels S, Novak S. Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database. Res Social Adm Pharm. 2014 Mar-Apr; 10(2):285-96. PMID: 23816495.
      View in: PubMed
    23. Fleming ML, Chandwani H, Barner JC, Weber SN, Okoro TT. Prescribers and pharmacists requests for prescription monitoring program (PMP) data: does PMP structure matter? J Pain Palliat Care Pharmacother. 2013 Jun; 27(2):136-42. PMID: 23688495.
      View in: PubMed
    24. Fleming M, Nemlekar P, Brown CM, Cantu R. Exploratory study of community pharmacists' perceptions about new or transferred prescription incentives. J Am Pharm Assoc (2003). 2012 Sep-Oct; 52(5):e53-8. PMID: 23023859.
      View in: PubMed
    25. Fleming M, Barner JC, Brown CM, Smith T. Treatment disparities for major depressive disorder: Implications for pharmacists. J Am Pharm Assoc (2003). 2011 Sep-Oct; 51(5):605-12. PMID: 21896458.
      View in: PubMed
    FLEMING's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description